Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
$19.67
-1.0%
$18.87
$14.40
$47.00
$1.31B1.33913,812 shs753,986 shs
Neogen Co. stock logo
NEOG
Neogen
$4.96
-17.3%
$5.98
$3.87
$18.58
$1.08B1.843.14 million shs23.42 million shs
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
$21.99
$21.98
$8.37
$23.11
$570.90M1.421.10 million shsN/A
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$31.08
+2.6%
$29.74
$23.77
$49.45
$2.10B0.131.08 million shs1.12 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
-1.01%+5.41%-3.06%-7.78%-39.96%
Neogen Co. stock logo
NEOG
Neogen
-17.33%-18.82%-12.06%-50.30%-68.81%
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
0.00%0.00%0.00%0.00%0.00%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
+2.61%-1.96%+12.24%-22.22%-28.16%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
1.8508 of 5 stars
4.50.00.00.02.70.00.0
Neogen Co. stock logo
NEOG
Neogen
3.2053 of 5 stars
3.31.00.00.01.93.32.5
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
N/AN/AN/AN/AN/AN/AN/AN/A
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
4.6388 of 5 stars
3.23.00.03.83.81.72.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
2.90
Moderate Buy$53.90174.02% Upside
Neogen Co. stock logo
NEOG
Neogen
2.50
Moderate Buy$9.0081.45% Upside
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
0.00
N/AN/AN/A
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
2.43
Hold$44.3342.64% Upside

Current Analyst Ratings Breakdown

Latest OXFD, QDEL, NEOG, and CLDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$44.00 ➝ $38.00
5/9/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$36.00 ➝ $31.00
5/9/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$46.00 ➝ $43.00
5/8/2025
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$45.00 ➝ $29.00
5/8/2025
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$44.00
5/6/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$80.00 ➝ $80.00
4/28/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$64.00
4/22/2025
Neogen Co. stock logo
NEOG
Neogen
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$6.40 ➝ $5.00
4/21/2025
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$38.00 ➝ $25.00
4/14/2025
Neogen Co. stock logo
NEOG
Neogen
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$13.00 ➝ $6.50
4/10/2025
Neogen Co. stock logo
NEOG
Neogen
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $13.00
(Data available from 6/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
$7.56M172.74N/AN/A$9.08 per share2.17
Neogen Co. stock logo
NEOG
Neogen
$906.00M1.19$0.51 per share9.80$14.52 per share0.34
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
$73.71M7.75$0.02 per share1,408.78$8.08 per share2.72
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$2.76B0.76$24.09 per share1.29$44.75 per share0.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
-$141.43M-$2.70N/AN/AN/A-1,544.32%-19.75%-18.86%8/14/2025 (Estimated)
Neogen Co. stock logo
NEOG
Neogen
-$9.42M-$2.23N/A10.12N/A-52.12%2.89%1.98%7/29/2025 (Estimated)
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
-$1.81M-$0.05N/AN/AN/A-30.51%-8.39%-7.63%N/A
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
-$2.03B-$4.97N/A9.68N/A-72.84%3.78%1.80%7/30/2025 (Estimated)

Latest OXFD, QDEL, NEOG, and CLDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
-$0.75-$0.81-$0.06-$0.81$1.08 million$0.70 million
5/7/2025Q1 2025
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$0.61$0.74+$0.13-$0.19$694.97 million$692.80 million
4/9/2025Q3 2025
Neogen Co. stock logo
NEOG
Neogen
$0.12$0.10-$0.02-$0.05$225.27 million$221.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
N/AN/AN/AN/AN/A
Neogen Co. stock logo
NEOG
Neogen
N/AN/AN/AN/AN/A
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
N/AN/AN/AN/AN/A
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
N/A
24.27
24.27
Neogen Co. stock logo
NEOG
Neogen
0.33
3.77
2.46
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
N/A
15.96
14.85
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
0.71
1.22
0.69

Institutional Ownership

CompanyInstitutional Ownership
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
N/A
Neogen Co. stock logo
NEOG
Neogen
96.73%
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
91.90%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
99.00%

Insider Ownership

CompanyInsider Ownership
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
3.80%
Neogen Co. stock logo
NEOG
Neogen
1.13%
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
4.33%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
0.79%
CompanyEmployeesShares OutstandingFree FloatOptionable
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
15066.38 million63.82 millionOptionable
Neogen Co. stock logo
NEOG
Neogen
2,110217.04 million214.49 millionOptionable
Oxford Immunotec Global PLC stock logo
OXFD
Oxford Immunotec Global
27325.96 millionN/ANot Optionable
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
7,00067.63 million66.58 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Celldex Therapeutics stock logo

Celldex Therapeutics NASDAQ:CLDX

$19.67 -0.20 (-1.01%)
As of 06/4/2025 04:00 PM Eastern

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.

Neogen stock logo

Neogen NASDAQ:NEOG

$4.96 -1.04 (-17.33%)
As of 06/4/2025 04:00 PM Eastern

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Oxford Immunotec Global stock logo

Oxford Immunotec Global NASDAQ:OXFD

Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, Europe, Asia, and internationally. The company develops its products using its T-SPOT technology platform that measures marker-specific cellular (T cells) responses at a single cell level and inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. It develops and markets T-SPOT.TB test used to test for tuberculosis; and reagents and methods to purify white blood cells for use in immunology assays. In addition, the company offers T-SPOT.CMV, an immune monitoring test for cytomegalovirus (CMV) for the quantification of effector T cells that respond to stimulation by antigens specific for CMV, as well as for the monitoring of CMV-seropositive responses in transplant recipients at various time-points post-transplantation applications. It serves independent laboratories, hospital systems, and public and private institutions. Oxford Immunotec Global PLC was founded in 2002 and is headquartered in Abingdon, the United Kingdom.

QuidelOrtho stock logo

QuidelOrtho NASDAQ:QDEL

$31.08 +0.79 (+2.61%)
As of 06/4/2025 04:00 PM Eastern

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.